Artificial intelligence–enhanced electrocardiography for detection of subclinical left ventricular dysfunction in cancer survivors
Artificial intelligence-enhanced electrocardiogram shows moderate discrimination for subclinical HF, with significant improvement in predictive accuracy when combined with CHERISH risk score among cancer survivors, and compares it with clinically-derived and electronic medical record-based HF risk scores.